当前位置: 100md首页 > 医学版 > 医学资料 > 更多 > BMJ临床肿瘤治疗进展增刊 > 正文
编号:11308700
21-应何时为妇女检测人乳头状瘤病毒.pdf
http://www.100md.com
第1页

    参见附件(45kb)。

    述评

    参考文献

    1 Mer ck News room. Mer ck′ s inve st igat ional vacc ine GARDASI LTM pre vented

    100 per cent of cervic al pre -ca ncers and non- invas ive c ervica l canc ers

    as sociated with HPV types 16 a nd 18 in ne w cl inical s tudy. P res s relea se 6 Oct

    2005. ( a cce ssed 17 Oc t 2005) .

    2 Wor ld He al th Orga nizat ion. WHO c onsultat ion on human pa pil lomavi rus

    vacc ine s . Wkly Epidemiol Rec 2005 ; 80: 299-301.

    3 Koutsky LA, Aul t KA, Whe ele r CM, Brown DR , Ba rr E , Alvar ez FB , et al .

    A cont rol led t rial of huma n pa pil lomavi rus type 16 vacc ine . N Engl J Med

    2002; 347 : 1645-51.

    4 Harper DM, Fra nco EL, Whee ler C, F erris DG, Jenkins D, Sc huind A, et

    al . Effica cy of a bivalent L1 vi rus -l ike part ic le va ccine in pre vent ion of

    infect ion wi th hum an pa pi l lomavi rus type s 16 a nd 18 in young women: a

    randomized c ontr ol le d t ria l . La ncet 2004 ; 364: 1757-65.

    5 Vi lla LL, Cos ta R LR , Pe tta CA, Andr ade R P , Aul t KA, Giuliano AR , et al .

    Prophylac tic quadrivalent human papil lomavirus ( types 6, 11, 16, a nd 18 )

    L1 vi rus -l ike par ticle vacc ine in young wome n: a randomized double -bl ind

    plac ebo- cont rol led mul t ic entr e phase II efficac y tr ia l . La ncet Oncol 2005; 6:

    271-8.

    6 Bosch F X, Lorinc z A, Munoz N, Mei je r CJ , Sha h KV. The c ausal re lat ion

    be twe en huma n papi l lomavi rus and cervic al ca nc er . J Cl in P a thol 2002; 55:

    244-65.

    7 Munoz N, Bosch FX, de Sanjose S , H erre ro R , Cas tel lsague X, Sha h KV, et

    al . Epidemiologic clas si fic ation of human papi lloma vi rus type s a s sociate d with

    cervic al ca ncer . N Engl J Med 2003; 348: 518 -27 .

    8 Parkin DM, Bra y F, F erlay J , P isa ni P . Global c ancer stat ist ics , 2002. CA

    Cancer J Cl in 2005 ; 55: 74-108.

    9 Cli ffor d GM, Ga llus S, Herre ro R , Munoz N, Snijders PJF , Vacca rel la S , et

    al . Worldwide dis tr ibut ion of huma n papi lloma vi rus types in c ytological ly

    normal women in the I nter na tional Age ncy for R esearc h on Cancer HPV

    pr eva lenc e surveys : a pooled a nalys is . La ncet 2005; 366: 991 -8.

    10 P eto J , Gi lham C, F le tc he r O, Mat the ws FE . The cer vic al ca ncer epidemic

    that sc reening has pre vented in the UK. Lancet 2004; 364: 249-56.

    11 NHS Ce rvical Ca ncer Scre ening P rogramme . Cervica l ca ncer - incidence,morta li ty a nd risk fa ctors. ( acc es se d 17 Oct 2005 ) .

    12 UK Col labora tive Group for HIV and STI Sur vei llanc e. F ocus on prevent ion.

    HIV a nd other sexua l ly tr a nsmit ted infect ions in the United Kingdom in 2003.

    London: Hea l th Pr otect ion Agency Cent re for Infect ions , 2004. ( a cces sed 17

    Oct 2005 ) .

    13 Johnson AM, Mercer CH, Erens R , Copa s AJ , McMa nus S, Well ings K, et a l .

    Sexua l beha viour in Bri tain: pa rtnerships, pra ct ices , a nd HIV risk beha viours.

    Lance t 2001; 358: 1835 -42 .

    14 Internat iona l F ina nce F a cil i ty for Immunisa tion. New I nterna tiona l F ina nce

    F aci li ty for Immunisa t ion Could Sa ve 10 Mi l lion Lives. P ress relea se 9 Sep

    2005. ( a cces sed 17 Oct 2005) .

    BMJ 2005; 331 : 915-6

    应何时为妇女检测人乳头瘤病毒

    该病毒检测用于宫颈癌筛查前景良好, 但仍需慎重

    When to test women for human papillomavirus

    Cervical screening using HPV testing shows great promise but warrants caution

    由于人们对人乳头瘤病毒( HPV) 以及宫颈癌

    病因的深入认识, 使预防策略成为可能 ......

您现在查看是摘要介绍页,详见PDF附件(45KB,2页)